Professor Simon Skene

Director of Surrey Clinical Trials Unit

Prof Skene has over 20 years’ experience as a medical statistician in teaching and research, including the design and analysis of studies investigating medicinal products, advanced therapies, diagnostic accuracy and surgery.

Prof Skene's appointment at University of Surrey combines the role of Director of the Clinical Trials Unit (CTU) with leadership in statistics to support decision based-practice in health and medicine. He is additionally Head of Department of Clinical and Experimental Medicine which brings the Clinical Trials Unit together with Surrey Clinical Research Facility and Surrey Sleep Research Centre in the newly refurbished Clinical Research Building. 

View Prof Skene's academic profile here.

Dr Agnieszka Michael MBBS PhD MRCP

Surrey Clinical Trials Unit Medical Director

Dr Michael qualified in medicine from Wroclaw University in Poland in 1994 and received a doctorate in cancer gene therapy from St George’s, University of London in 2006.  She trained in Medical Oncology at the Royal Marsden Hospital, St George’s Hospital, London, and Guys and Thomas’s Hospital.  She has been working at the University of Surrey since 2008, and is a Clinical Reader in Medical Oncology. She also works as a Consultant Medical Oncologist at the Royal Surrey County Hospital. Dr Michael’s key research specialities are in the areas of Ovarian Cancer and urological malignancies .

Dr Michael is a member of NCRN Clinical Studies Group for Gynaecological Cancers and has experience in running national and international clinical trials for new cancer treatments as a local Principal Investigator and a UK Chief Investigator. She has recently been successful in obtaining CTAAC/CRUK approval for a new investigator-driven multi-centre study of a TroVax vaccine in ovarian cancer (TRIOC) which is due to run in 10 centres in UK. Dr Michael also supervises a number of translational sciences projects, mainly in gynaecological cancers and has set up a tissue bank based at at the University of Surrey, which is now become a part of the NCRI on Core UK-Confederation of Cancer Biobanks (CCB). 

View Dr Michael's academic profile here.

Trim content